Fig. 1From: Promises and challenges of personalized medicine to guide ARDS therapyBiologic mechanisms in ARDS that may be targeted by various personalizable therapies. MSC mesenchymal stromal cells, CFH cell-free hemoglobin, F2-IsoP F2 isoprostanes, APAP acetaminophen. Figure created in BioRenderBack to article page